Explore 3 Stock Ideas & Industry Insights Download Free Report

Heartbeam Inc

Healthcare US BEAT

0.705USD
-0.0051(0.72%)

Last update at 2026-06-23T18:51:00Z

Day Range

0.710.74
LowHigh

52 Week Range

0.544.00
LowHigh

Fundamentals

  • Previous Close 0.71
  • Market Cap49.12M
  • Volume239047
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-21.09900M
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-0.62

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -21.01500M -19.44800M -14.63900M -12.96200M -4.42800M
Minority interest - - - - -
Net income -21.01500M -19.44800M -14.63900M -12.82700M -6.59300M
Selling general administrative 7.69M 8.84M 8.52M 7.35M 2.03M
Selling and marketing expenses - - 8.51M - -
Gross profit -0.04000M -0.00700M - - -
Reconciled depreciation 0.04M 0.00700M 0.00000M - -
Ebit -21.17900M -19.88700M -14.63900M -13.03100M -2.28500M
Ebitda -21.13900M -19.88000M 0.68M -13.03100M -2.26300M
Depreciation and amortization 0.04M 0.00700M 15.31M 0.14M 0.02M
Non operating income net other - - - - -
Operating income -21.13900M -19.88700M -15.31400M -13.03100M -2.28500M
Other operating expenses 21.14M 19.89M 15.31M 13.03M 2.29M
Interest expense - - - 0.07M 2.17M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.12M 0.45M 0.68M - -
Net interest income 0.12M 0.45M 0.47M 0.07M -2.16500M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - -0.01531M -0.13500M 2.17M
Total revenue 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Total operating expenses 21.14M 19.89M 15.31M 13.03M 2.29M
Cost of revenue 0.04M 0.00700M - - -
Total other income expense net 0.12M 0.44M 0.68M 0.07M -2.14300M
Discontinued operations - - - - -
Net income from continuing ops -21.01500M -19.44800M -14.47200M -12.96200M -4.42800M
Net income applicable to common shares - - - -12.96200M -4.42800M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 5.84M 3.28M 17.13M 4.04M 14.00M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.20M 0.39M 0.64M 0.45M 0.81M
Total liab 3.24M 1.62M 1.19M 1.67M 0.59M
Total stockholder equity 2.60M 1.65M 15.94M 2.37M 13.41M
Deferred long term liab - - - - -
Other current liab 3.24M 1.09M 1.19M 1.67M 0.59M
Common stock 0.00400M 0.00300M 0.00300M 0.00100M 0.00100M
Capital stock 0.00400M 0.00300M 0.00300M 0.00100M 0.00100M
Retained earnings -77.28800M -56.27300M -36.82500M -22.18600M -9.22400M
Other liab - - - - -
Good will - - - - -
Other assets - - - 0.45M 0.81M
Cash 4.38M 2.38M 16.19M 3.59M 13.19M
Cash and equivalents - - - - -
Total current liabilities 3.24M 1.62M 1.19M 1.67M 0.59M
Current deferred revenue - - - - -
Net debt -4.38000M -2.37700M -16.18900M -3.59400M -13.19200M
Short term debt - - - - -
Short long term debt - - - - -
Short long term debt total - - - - -
Other stockholder equity 79.89M 57.92M 52.76M 24.56M 22.63M
Property plant equipment - - - - -
Total current assets 4.68M 2.77M 16.82M 4.04M 14.00M
Long term investments - - - - -
Net tangible assets - - - 2.37M 13.41M
Short term investments - - - - -
Net receivables - - - - -
Long term debt - - - - -
Inventory 0.10M 0.00000M - - -
Accounts payable 1.05M 0.53M 0.00119M 0.00167M 0.59M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.06M 0.06M 0.05M - -
Deferred long term asset charges - - - - -
Non current assets total 1.16M 0.51M 0.31M 0.00000M 0.00000M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 0.00000M -0.20100M -0.25600M 0.00000M -
Change to liabilities - - - 1.53M -0.35700M
Total cashflows from investing activities -0.60000M -0.20100M - - -
Net borrowings - - - - 1.69M
Total cash from financing activities 16.59M 0.87M 24.99M 0.35M 16.40M
Change to operating activities - - - 0.36M -0.77900M
Net income -21.01500M -19.44800M -14.63900M -12.96200M -4.42800M
Change in cash 2.00M -13.80600M 12.64M -9.59800M 13.17M
Begin period cash flow 2.43M 16.24M 3.59M 13.19M 0.02M
End period cash flow 4.44M 2.43M 16.24M 3.59M 13.19M
Total cash from operating activities -13.98800M -14.47100M -12.09300M -9.94800M -3.23000M
Issuance of capital stock 16.58M 0.73M 24.76M 0.35M 14.71M
Depreciation 0.04M 0.00700M - - -
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory -0.10300M 0.00000M - - -
Change to account receivables - - - - -
Sale purchase of stock - - - - -
Other cashflows from financing activities 16.59M 0.14M 0.23M 0.00200M 1.72M
Change to netincome - - - 1.12M 2.33M
Capital expenditures 0.60M 0.20M 0.26M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 1.61M 0.67M -0.66200M 1.89M -1.13600M
Stock based compensation 5.15M 4.30M 3.21M 1.12M 0.19M
Other non cash items 0.23M 0.67M 3.21M 1.12M 2.14M
Free cash flow -14.58800M -14.67200M -12.34900M -9.94800M -3.23000M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
BEAT
Heartbeam Inc
-0.0051 0.72% 0.70 - - - 18.96 -2.9947
VEEV
Veeva Systems Inc Class A
5.55 3.62% 158.71 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc
- -% 8.55 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc
0.02 0.38% 5.23 31.84 26.25 0.05 4.60 0.04 0.12
BTSG
BrightSpring Health Services, Inc. Common Stock
0.35 0.52% 67.55 100.22 40.65 0.69 4.92 0.92 25.80

Reports Covered

Stock Research & News

Profile

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.

Heartbeam Inc

2118 Walsh Avenue, Santa Clara, CA, United States, 95050

Key Executives

Name Title Year Born
Mr. Richard M. Ferrari Exec. Chairman 1954
Dr. Branislav Vajdic Ph.D. Founder, Pres, CEO & Director 1955
Mr. Richard D. Brounstein CFO & Treasurer 1950
Mr. Ken Persen Chief Technology Officer NA
Dr. Jon Hunt Ph.D. Exec. VP & Chief Bus. Officer 1956
Dr. Peter J. Fitzgerald FACC, M.D., Ph.D. Chief Medical Officer 1957
Mr. Richard M. Ferrari Executive Chairman 1954
Dr. Branislav Vajdic Ph.D. Founder, CEO & Director 1955
Mr. Robert P. Eno President & Chief Business Officer NA
Mr. Kenneth Persen Chief Technology Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.